Hoeksema Timothy E - 07 May 2025 Form 4 Insider Report for MARCUS CORP (MCS)

Role
Director
Signature
/s/ Steven R. Barth, Attorney-in-Fact for Timothy E. Hoeksema
Issuer symbol
MCS
Transactions as of
07 May 2025
Transactions value $
$24,993
Form type
4
Filing time
09 May 2025, 17:18:53
Previous filing
30 Dec 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HOEKSEMA TIMOTHY E Director 770 NORTH WATER ST, MILWAUKEE /s/ Steven R. Barth, Attorney-in-Fact for Timothy E. Hoeksema 09 May 2025 0001093035

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MCS Common Stock Award $25K +1.54K +3.54% $16.25 45K 07 May 2025 Direct F1
holding MCS Common Stock 15K 07 May 2025 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MCS Stock Option (Right to Buy) 1K 07 May 2025 Common Stock 1K $19.65 Direct F3
holding MCS Stock Option (Right to Buy) 583 07 May 2025 Common Stock 583 $18.97 Direct F3
holding MCS Stock Option (Right to Buy) 1K 07 May 2025 Common Stock 1K $31.55 Direct F3
holding MCS Stock Option (Right to Buy) 1K 07 May 2025 Common Stock 1K $27.20 Direct F3
holding MCS Stock Option (Right to Buy) 1K 07 May 2025 Common Stock 1K $38.51 Direct F3
holding MCS Stock Option (Right to Buy) 1K 07 May 2025 Common Stock 1K $32.60 Direct F3
holding MCS Stock Option (Right to Buy) 750 07 May 2025 Common Stock 750 $17.95 Direct F3
holding MCS Stock Option (Right to Buy) 1.44K 07 May 2025 Common Stock 1.44K $14.25 Direct F3
holding MCS Stock Option (Right to Buy) 1.46K 07 May 2025 Common Stock 1.46K $14.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted by Issuer in consideration of service as a director.
F2 By the Timothy and Janis Hoeksema Revocable Trust U/A Dated 01/04/2010.
F3 Granted pursuant to The Marcus Corporation 2004 Equity and Incentive Awards Plan.